Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

NCT00991289 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

NIH

Sponsor class

Conditions

HIV Infection
Hepatitis C Infection

Interventions

DRUG: Nitazoxanide (NTZ)
DRUG: Pegylated interferon alfa-2a (PEG)
DRUG: Ribavirin (RBV)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)